1 year return (CAGR)
-
Lakewood-Amedex Biotherapeutics Inc. Common Stock Exchange (NASDAQ, USD)
LABT
2.05
+0.06 (+3.02%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.86M
Price/Sales
-
Ent value
2.90M
Price/Book
1.12
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.99 |
| Daily high | 2.08 |
| Daily low | 1.93 |
| Daily Volume | 357K |
| All-time high | 7.35 |
| 1y analyst estimate | 12.00 |
| Beta | - |
| EPS (TTM) | -5.18 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LABT | S&P500 | |
| Current price drop from All-time high | -72.11% | -0.56% |
| Highest price drop | -91.84% | -56.47% |
| Date of highest drop | 17 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -69.04% | -10.68% |
| Avg time to new high | 52 days | 12 days |
| Max time to new high | 103 days | 1805 days |
